IP Library Granted Patent US 8,915,895
Granted Patent B2
US 8,915,895 · App. 13/691,538 · Granted Dec 23, 2014

Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,915,895
App. No.
13/691,538
Granted
Dec 23, 2014
Kind
B2
Abstract

A reduced pressure treatment system includes a reduced pressure source and a reduced pressure dressing. The dressing includes an interface layer adapted to be positioned at a tissue site and an absorbent layer in fluid communication with the interface layer to absorb liquid from at least one of the interface layer and the tissue site. A diverter layer is positioned adjacent the absorbent layer, and the diverter layer includes a plurality of apertures in fluid communication with the absorbent layer to distribute a reduced pressure to the absorbent layer. A cover is positioned over the diverter layer to maintain the reduced pressure at the tissue site.

Claims (34)

1. A system for treating a tissue site, comprising:

a reduced pressure source;

a dressing adapted to be in fluid communication with the reduced pressure source to distribute reduced pressure to the tissue site, the reduced pressure source positioned external to the dressing, the dressing comprising:

an absorbent layer adapted to be positioned at the tissue site to absorb liquid from the tissue site, the absorbent layer having a perimeter region and a center region; and

a diverter layer adapted to be positioned in fluid communication between the absorbent layer and the reduced pressure source to direct the liquid radially outward from the center region of the absorbent layer to the perimeter region of the absorbent layer; and

a cover adapted to be positioned over the dressing to provide a fluid seal relative to the tissue site.

2. The system of claim 1 , further comprising an interface layer adapted to be positioned between the tissue site and the absorbent layer, wherein the interface layer is hydrophobic.

3. The system of claim 1 , wherein the absorbent layer comprises a super absorbent fiber.

4. The system of claim 1 , further comprising a liquid-air separator positioned between the absorbent layer and the cover.

5. The system of claim 1 , further comprising a seal layer adapted to be positioned between the cover and tissue surrounding the tissue site.

6. The system of claim 1 , wherein the diverter layer includes a plurality of ridges on a surface of the diverter layer that define a plurality of channels between the ridges.

7. The system of claim 1 , wherein the diverter layer comprises a substantially liquid-impermeable material.

8. The system of claim 1 , wherein the diverter layer has a perimeter dimension that is smaller than a perimeter dimension of the absorbent layer such that reduced pressure flow is directed around at least one perimeter edge of the diverter layer.

9. The system of claim 1 , wherein the diverter layer has a surface area smaller than a surface area of the absorbent layer such that reduced pressure flow is directed around at least one perimeter edge of the diverter layer.

10. The system of claim 1 , the diverter layer having a perimeter edge positioned substantially within the perimeter region of the absorbent layer and away from the center region of the absorbent layer.

11. The system of claim 1 , wherein the diverter layer is positioned such that reduced pressure is applied to the absorbent layer substantially through the perimeter region of the absorbent layer and away from the center region of the absorbent layer.

12. A system for treating a tissue site, comprising:

a reduced pressure source;

a dressing adapted to be in fluid communication with the reduced pressure source to distribute reduced pressure to the tissue site, the reduced pressure source positioned external to the dressing, the dressing comprising:

an absorbent layer adapted to be positioned at the tissue site to absorb liquid from the tissue site, the absorbent layer having a perimeter region and a center region; and

a diverter layer adapted to be positioned in fluid communication between the absorbent layer and the reduced pressure source, wherein the diverter layer has a surface area smaller than a surface area of the absorbent layer such that reduced pressure flow is directed around at least one perimeter edge of the diverter layer; and

a cover adapted to be positioned over the dressing to provide a fluid seal relative to the tissue site.

13. The system of claim 12 , wherein the diverter layer has a perimeter dimension that is smaller than a perimeter dimension of the absorbent layer such that reduced pressure flow is directed around at least one perimeter edge of the diverter layer.

14. The system of claim 12 , the diverter layer having a perimeter edge positioned substantially within the perimeter region of the absorbent layer and away from the center region of the absorbent layer.

15. The system of claim 12 , wherein the diverter layer is positioned such that reduced pressure is applied to the absorbent layer substantially through the perimeter region of the absorbent layer and away from the center region of the absorbent layer.

16. A dressing adapted to be in fluid communication with an external reduced pressure source to distribute reduced pressure to a tissue site, the dressing comprising:

an absorbent layer adapted to be positioned at the tissue site to absorb liquid from the tissue site, the absorbent layer having a perimeter region and a center region; and

a diverter layer adapted to be positioned in fluid communication between the absorbent layer and the reduced pressure source to direct the liquid radially outward from the center region of the absorbent layer to the perimeter region of the absorbent layer.

17. The dressing of claim 16 , further comprising an interface layer adapted to be positioned between the tissue site and the absorbent layer, wherein the interface layer is hydrophobic.

18. The dressing of claim 16 , wherein the diverter layer comprises a substantially liquid-impermeable material.

19. The dressing of claim 16 , wherein the diverter layer has a perimeter dimension that is smaller than a perimeter dimension of the absorbent layer such that reduced pressure flow is directed around at least one perimeter edge of the diverter layer.

20. The dressing of claim 16 , wherein the diverter layer has a surface area smaller than a surface area of the absorbent layer such that reduced pressure flow is directed around at least one perimeter edge of the diverter layer.

21. The dressing of claim 16 , the diverter layer having a perimeter edge positioned substantially within the perimeter region of the absorbent layer and away from the center region of the absorbent layer.

22. The dressing of claim 16 , wherein the diverter layer is positioned such that reduced pressure is applied to the absorbent layer substantially through the perimeter region of the absorbent layer and away from the center region of the absorbent layer.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR PREVIOUSLY RECORDED ON REEL 029408 FRAME 0359. ASSIGNOR(S) HEREBY CONFIRMS THE ALDAN MARCUS TOUT. Recorded Apr 23, 2014
From: JAEB, JONATHAN PAUL; COULTHARD, RICHARD DANIEL JOHN; ROBINSON, TIMOTHY MARK; LOCKE, CHRISTOPHER BRIAN; TOUT, AIDAN MARCUS
To: KCI LICENSING, INC
Reel/Frame 032744/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2012
From: JAEB, JONATHAN PAUL; COULTHARD, RICHARD DANIEL JOHN; ROBINSON, TIMOTHY MARK; LOCKE, CHRISTOPHER BRIAN; TOUT, ALDAN MARCUS
To: KCI LICENSING, INC.
Reel/Frame 029408/0359 →